Q

uniQure NV
D

QURE

54.920
USD
0.45
(0.82%)
مغلق
حجم التداول
108,057
الربح لكل سهم
-3
العائد الربحي
-
P/E
-14
حجم السوق
3,383,279,103
أصول ذات صلة الأخبار المقالات

العنوان: uniQure NV

القطاع: Healthcare
الصناعة: Biotechnology
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.